BridgeBio Pharma (BBIO) FCF Margin (QoQ) (2020 - 2026)
BridgeBio Pharma (BBIO) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BridgeBio Pharma | 15.60 Bn | 14.89 Bn | 228.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,210.00 |
| Mar 31, 2026 | -6,416.00 |
| Dec 31, 2025 | 5,349.00 |
| Sep 30, 2025 | -1,782.00 |
| Jun 30, 2025 | 9,785.00 |
| Mar 31, 2025 | 315,000.00 |
| Dec 31, 2024 | 329,594.00 |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | 357,885.00 |
| Mar 31, 2024 | 704,336.00 |
| Dec 31, 2023 | -360,385.00 |
| Sep 30, 2023 | 338,981.00 |
| Jun 30, 2023 | 97,074.00 |
| Mar 31, 2023 | -266,353.00 |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | -3.90 Mn |
| Jun 30, 2022 | 948,216.00 |
| Mar 31, 2022 | -807,994.00 |
| Dec 31, 2021 | 366,238.00 |
| Sep 30, 2021 | -493,498.00 |